Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.

[1]  D. Scollard,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.

[2]  C. Watson,et al.  Regulation of aromatase activity within the breast , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  F. Robertson,et al.  Cyclooxygenase-2 gene expression in human breast cancer. , 1997, International journal of oncology.

[4]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[5]  P. Remington,et al.  Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  C. Mendelson,et al.  Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. , 1996, Endocrinology.

[7]  D. Rose,et al.  Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. , 1996, Cancer research.

[8]  S. Wilczynski,et al.  Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  K. Subbaramaiah,et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.

[10]  M. Schrey,et al.  Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin‐1β and phorbol ester: Dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function , 1996, International journal of cancer.

[11]  K. Wu,et al.  Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. , 1996, The Journal of laboratory and clinical medicine.

[12]  J. Otto,et al.  Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site (*) , 1996, The Journal of Biological Chemistry.

[13]  K. Namboodiri,et al.  Nonsteroidal antiinflammatory drugs and breast cancer. , 1996, Epidemiology.

[14]  R. DuBois,et al.  Prostaglandin endoperoxide synthase: why two isoforms? , 1996, The American journal of physiology.

[15]  H. Herschman.  Prostaglandin synthase 2. , 1996, Biochimica et biophysica acta.

[16]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[17]  K. Namboodiri,et al.  Epidemiologic-study of nonsteroidal antiinflammatory drugs and breast-cancer. , 1995, Oncology reports.

[18]  K. Namboodiri,et al.  Breast cancer and NSAID use: heterogeneity of effect in a case-control study. , 1995, Preventive medicine.

[19]  K. Seibert,et al.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Ito,et al.  Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.

[21]  J. Vane,et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Bulun.  A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription [published erratum appears in J Clin Endocrinol Metab 1994 Feb;78(2):494] , 1993 .

[23]  S. Bulun,et al.  A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. , 1993, The Journal of clinical endocrinology and metabolism.

[24]  B. Rigas,et al.  Altered eicosanoid levels in human colon cancer. , 1993, The Journal of laboratory and clinical medicine.

[25]  A. Ford-hutchinson,et al.  Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.

[26]  G. Kelloff,et al.  Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. , 1993, Carcinogenesis.

[27]  E. Lephart,et al.  Diverse mechanisms of control of aromatase gene expression , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  A. Purohit,et al.  Control of aromatase activity in breast cancer cells: The role of cytokines and growth factors , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  Evan R. Simpson,et al.  Tissue-specific promoters regulate aromatase cytochrome P450 expression , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  J. Wallace,et al.  Prostaglandins, NSAIDs, and cytoprotection. , 1992, Gastroenterology clinics of North America.

[31]  M. Ghilchik,et al.  Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. , 1992, The Journal of endocrinology.

[32]  C. Mendelson,et al.  Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. , 1991, Molecular endocrinology.

[33]  M. Sanghera,et al.  Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies. , 1991, Endocrinology.

[34]  C. Ip,et al.  A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid. , 1989, Carcinogenesis.

[35]  M. Reed,et al.  Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies , 1987, Steroids.

[36]  J. Kellis,et al.  Purification and characterization of human placental aromatase cytochrome P-450. , 1987, The Journal of biological chemistry.

[37]  A. Bennett,et al.  Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. , 1987, Gut.

[38]  M. Brennan,et al.  Relationship of tumor prostaglandin levels to early recurrence in women with primary breast cancer: clinical update. , 1986, Invasion & metastasis.

[39]  A. Bennett,et al.  The production of prostanoids in human cancers, and their implications for tumor progression. , 1986, Progress in lipid research.

[40]  S. Juhn,et al.  Prostaglandins in squamous cell carcinoma of the head and neck: A preliminary study , 1985, The Laryngoscope.

[41]  A. Fulton.  In vivo effects of indomethacin on the growth of murine mammary tumors. , 1984, Cancer research.

[42]  W. Miller,et al.  Prostaglandins in human mammary cancer. , 1984, British Journal of Cancer.

[43]  D. Mccormick,et al.  Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent. , 1983, British Journal of Cancer.

[44]  T. Narisawa,et al.  Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. , 1983, Carcinogenesis.

[45]  A. Wilson,et al.  Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

[46]  J. Jacquemier,et al.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. , 1980, Journal of the National Cancer Institute.

[47]  A. Bennett,et al.  Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers [proceedings]. , 1979, British journal of pharmacology.

[48]  T. Żebro,et al.  PROSTAGLANDINS AND BREAST CANCER , 1977, The Lancet.

[49]  H. Potter,et al.  Estrogen Receptor and Natural Course of Breast Cancer , 1976, Annals of surgery.